Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high‐dose cytarabine and mitoxantrone

K. Hayward designed the research study and analysed the data. The study and Nicholas K. Hayward is funded by the National Health and Medical Research Council (NHMRC; 1093017, 1117663), Antonia L. Pritchard is funded by Highlands and Islands Enterprise (HMS 9353763), Kelly M. Brooks is funded by Cure Cancer Australia, Vaishnavi Nathan is supported by an Australian Government Research Training Programme (RTP) Scholarship. The participants were recruited under ethics approval granted by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (HREC reference number: HREC/14/QPAH/495).

• Publication year

  2020

• Venue

  British Journal of Haematology

• Publication date

  2020-11-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bjh.17220PMID 33222152
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss-of-function variants in POT1 predispose to uveal melanoma

  2020cited by this paper
• A Phase Ib/II Study of the BCL-2 Inhibitor Venetoclax in Combination with Standard Intensive AML Induction/Consolidation Therapy with FLAG-IDA in Patients with Newly Diagnosed or Relapsed/Refractory AML

  2019cited by this paper
• Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

  2019cited by this paper
• Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review

  2018cited by this paper
• Shelterin-Mediated Telomere Protection.

  2018cited by this paper
• Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma

  2018cited by this paper
• Germline mutations in candidate predisposition genes in individuals with cutaneous melanoma and at least two independent additional primary cancers

  2018cited by this paper
• No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden

  2017cited by this paper
• Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.

  2016cited by this paper
• Clonal Hematopoiesis of Indeterminate Potential.

  2016cited by this paper
• A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li–Fraumeni-like families

  2015cited by this paper
• Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

  2014cited by this paper
• Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

  2014cited by this paper
• POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

  2013cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Reversible Foetal Cerebral Ventriculomegaly and Cardiomyopathy under Chemotherapy for Maternal AML

  2009cited by this paper
• POT1 Association with TRF2 Regulates Telomere Length

  2009cited by this paper
• Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads

  2009cited by this paper
• Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling1

  2007cited by this paper
• Joint Effects of GermLine p 53 Mutation and Sex on Cancer Risk in Li-Fraumeni Syndrome

  2006cited by this paper
• Familial aggregation of lymphoplasmacytic lymphoma with non-Hodgkin lymphoma and other neoplasms

  2005cited by this paper
• Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.

  2001cited by this paper
• Bcl-2 gene family in the nervous system.

  1997cited by this paper
• Intrauterine growth curves based on ultrasonically estimated foetal weights

  1996cited by this paper
• Fetal biometry at 14–40 weeks' gestation

  1994cited by this paper
• Long-term follow-up of children born to mothers with acute leukemia during pregnancy.

  1988cited by this paper

• Acute leukemia during pregnancy: a single center experience with 23 cases, 2012-2022 and literature review.

  2026cites this paper
• Protective effect of alpha‑lipoic acid against in utero cytarabine exposure-induced hepatotoxicity in rat female neonates

  2024cites this paper
• Chronic Lymphocytic Leukemia in Pregnancy: A Review of the Available Literature and the Pharmacological Challenges in Management

  2024cites this paper
• Delayed Severe Hemolytic Transfusion Reaction During Pregnancy in a Woman with β-Thalassemia Intermediate: Successful Outcome After Eculizumab Administration

  2021cites this paper
• Cytarabine/mitoxantrone/venetoclax

  2021cites this paper